A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses
暂无分享,去创建一个
[1] C. Rizzo,et al. Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013). , 2016, Journal of Medical Microbiology.
[2] Y. Arakawa,et al. A Novel IgM‐capture enzyme‐linked immunosorbent assay using recombinant Vag8 fusion protein for the accurate and early diagnosis of Bordetella pertussis infection , 2016, Microbiology and immunology.
[3] R. Saito,et al. Concentrations of Immunoglobulin G Antibodies Against Pertussis Toxin Does Not Decrease Over a Long Period of Time in Japan , 2015, Internal medicine.
[4] K. Shibayama,et al. Laboratory-based surveillance of pertussis using multitarget real-time PCR in Japan: evidence for Bordetella pertussis infection in preteens and teens , 2015, New microbes and new infections.
[5] Meng Chen,et al. Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study , 2015, Human vaccines & immunotherapeutics.
[6] F. Mooi,et al. Seroprevalence of Pertussis in The Gambia , 2015, The Pediatric infectious disease journal.
[7] I. Lutsar,et al. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia. , 2014, Vaccine.
[8] S. Lambert,et al. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology , 2014, Expert review of vaccines.
[9] S. Lee,et al. Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G , 2014, Journal of Korean medical science.
[10] T. Clark. Changing pertussis epidemiology: everything old is new again. , 2014, The Journal of infectious diseases.
[11] K. Shibayama,et al. Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan , 2013, PloS one.
[12] G. Amirthalingam. Strategies to control pertussis in infants , 2013, Archives of Disease in Childhood.
[13] C. Kenyon,et al. Waning Immunity to Pertussis Following 5 Doses of DTaP , 2013, Pediatrics.
[14] J. Liese,et al. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate. , 2013, Journal of immunological methods.
[15] J. Liese,et al. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. , 2013, Vaccine.
[16] J. Mertsola,et al. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. , 2012, Vaccine.
[17] K. Krogfelt,et al. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay* , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[18] F. Mooi,et al. Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis , 2010, PloS one.
[19] G. Berbers,et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories , 2010, European Journal of Clinical Microbiology & Infectious Diseases.
[20] K. Krogfelt,et al. Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera. , 2009, Diagnostic microbiology and infectious disease.
[21] I. Srugo,et al. What is new in pertussis? , 2007, European Journal of Pediatrics.
[22] E. Hewlett,et al. Pertussis — Not Just for Kids , 2005 .
[23] E. Hewlett,et al. Clinical practice. Pertussis--not just for kids. , 2005, The New England journal of medicine.
[24] P. van Damme,et al. Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). , 2003, Vaccine.
[25] S. Halperin,et al. Pertussis of adults and infants. , 2002, The Lancet. Infectious diseases.
[26] M. Iwaki,et al. Distribution of pertussis antibodies among different age groups in Japan. , 2002, Vaccine.
[27] L. Salleras,et al. The seroepidemiology of B. pertussis infection in Catalonia, Spain , 2001, Epidemiology and Infection.
[28] J. Gornbein,et al. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] S. Barenkamp,et al. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis , 1992, Infection and immunity.
[30] R. Möllby,et al. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. , 1991, The Journal of infectious diseases.
[31] H. Sato,et al. An improved ELISA system for the measurement of IgG antibodies against pertussis toxin (PT) and filamentous hemagglutinin (FHA) in human sera. , 1991, Developments in biological standardization.
[32] I. Krantz,et al. Toxin-neutralizing antibodies in patients with pertussis, as determined by an assay using Chinese hamster ovary cells. , 1988, The Journal of infectious diseases.
[33] H. Sato,et al. Effect of monoclonal antibody to pertussis toxin on toxin activity , 1987, Infection and immunity.